Suppr超能文献

治疗钾紊乱:去除病因,但避免过度治疗。

Treating potassium disturbances: kill the killers but avoid overkill.

作者信息

Vanholder R, Van Biesen W, Nagler E V

机构信息

a Nephrology Section, Department of Internal Medicine , University Hospital Ghent , Belgium.

出版信息

Acta Clin Belg. 2019 Aug;74(4):215-228. doi: 10.1080/17843286.2018.1531206. Epub 2018 Oct 24.

Abstract

OBJECTIVES

In this publication, we review the definitions, symptoms, causes, differential diagnoses and therapies of hypokalemia and hyperkalemia.

METHODS

Comprehensive tables and diagnostic algorithms are provided when appropriate.

RESULTS AND CONCLUSIONS

Although both hypokalemia and hyperkalemia may be life-threatening, this is essentially the case with severe changes (serum potassium < 2.5 or > 6.5 mmol/L), the presence of symptoms or electrocardiographic deviations, the association with aggravating factors (e.g. digitalis intake) and/or rapid acute changes. Only these truly need an emergency therapeutic approach. In all other cases, a careful consideration of the causes and their correction should prevail over additional approaches to modify serum potassium concentration. Although most therapeutic approaches to both hypokalemia and hyperkalemia have been well established since many years, recently two new intestinal potassium binders have been introduced on the market. It remains to be elucidated whether these drugs truly have an additional role on top of the existing treatments.

摘要

目的

在本出版物中,我们回顾低钾血症和高钾血症的定义、症状、病因、鉴别诊断及治疗方法。

方法

在适当的时候提供综合表格和诊断算法。

结果与结论

尽管低钾血症和高钾血症均可能危及生命,但本质上只有在严重变化(血清钾<2.5或>6.5 mmol/L)、出现症状或心电图异常、伴有加重因素(如服用洋地黄)和/或快速急性变化时才会如此。只有这些情况真正需要紧急治疗方法。在所有其他情况下,仔细考虑病因并加以纠正应优先于其他改变血清钾浓度的方法。尽管多年来针对低钾血症和高钾血症的大多数治疗方法已得到充分确立,但最近有两种新型肠道钾结合剂已投放市场。这些药物在现有治疗之外是否真的具有额外作用仍有待阐明。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验